Literature DB >> 9889229

Stability of Mycobacterium tuberculosis IS6110 restriction fragment length polymorphism patterns and spoligotypes determined by analyzing serial isolates from patients with drug-resistant tuberculosis.

S Niemann1, E Richter, S Rüsch-Gerdes.   

Abstract

The stability of Mycobacterium tuberculosis IS6110 fingerprint patterns and spoligotypes has been assessed by analyzing serial isolates from patients with drug-resistant tuberculosis. Altogether, 165 M. tuberculosis isolates obtained from 56 patients have been analyzed. The time spans between the first and the last or a changed isolate from one patient ranged from 1 to 772 days. Among the 56 patients, 5 (9%) were infected with isolates with changes in their IS6110 fingerprint patterns. According to the total number of strains analyzed, 5% of the subsequent isolates showed variations in their IS6110 restriction fragment length polymorphism patterns compared to the pattern of the first isolates. Up to 10 isolates from one patient sampled at time intervals of up to 772 days with no changes in their IS6110 patterns have been analyzed. A statistically significant correlation could be found between changes in insertion sequence (IS) patterns and the increased time intervals over which the isolates were obtained, whereas changes in IS patterns are not correlated to changes in the drug resistance of the isolates. In contrast to the observed variations in IS6110 fingerprint patterns, no changes in the spoligotypes of the isolates analyzed could be found. In conclusion, our results confirm that the IS6110 fingerprint patterns of M. tuberculosis isolates have high degrees of stability. Compared to IS6110, the direct repeat (DR) region, which is the basis for spoligotyping, has a lower rate of change. Partial deletions, e.g., deletions induced by homologous recombination between the repetitive DR elements, could not be detected in this study.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9889229      PMCID: PMC84323     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis.

Authors:  D van Soolingen; P W Hermans; P E de Haas; D R Soll; J D van Embden
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

2.  IS6110: conservation of sequence in the Mycobacterium tuberculosis complex and its utilization in DNA fingerprinting.

Authors:  M D Cave; K D Eisenach; P F McDermott; J H Bates; J T Crawford
Journal:  Mol Cell Probes       Date:  1991-02       Impact factor: 2.365

Review 3.  Epidemiology of tuberculosis by DNA fingerprinting.

Authors:  D van Soolingen; P W Hermans
Journal:  Eur Respir J Suppl       Date:  1995-09

4.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

5.  DNA fingerprints of Mycobacterium tuberculosis do not change during the development of resistance to various antituberculous drugs.

Authors:  L Rigouts; F Portaels
Journal:  Tuber Lung Dis       Date:  1994-04

6.  Characterization of a Mycobacterium tuberculosis insertion sequence, IS6110, and its application in diagnosis.

Authors:  D Thierry; A Brisson-Noël; V Vincent-Lévy-Frébault; S Nguyen; J L Guesdon; B Gicquel
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

7.  Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis.

Authors:  D van Soolingen; P E de Haas; P W Hermans; P M Groenen; J D van Embden
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

8.  Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology.

Authors:  P W Hermans; F Messadi; H Guebrexabher; D van Soolingen; P E de Haas; H Heersma; H de Neeling; A Ayoub; F Portaels; D Frommel
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

9.  Characterization of a Mycobacterium tuberculosis insertion sequence belonging to the IS3 family.

Authors:  R A McAdam; P W Hermans; D van Soolingen; Z F Zainuddin; D Catty; J D van Embden; J W Dale
Journal:  Mol Microbiol       Date:  1990-09       Impact factor: 3.501

10.  Stability of DNA fingerprint pattern produced with IS6110 in strains of Mycobacterium tuberculosis.

Authors:  M D Cave; K D Eisenach; G Templeton; M Salfinger; G Mazurek; J H Bates; J T Crawford
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

View more
  43 in total

1.  Stability of IS6110 restriction fragment length polymorphism patterns of multidrug-resistant Mycobacterium tuberculosis strains.

Authors:  S Niemann; E Richter; S Rüsch-Gerdes
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Characterization of Mycobacterium tuberculosis isolates from patients in Houston, Texas, by spoligotyping.

Authors:  H Soini; X Pan; A Amin; E A Graviss; A Siddiqui; J M Musser
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Use of genetic distance as a measure of ongoing transmission of Mycobacterium tuberculosis.

Authors:  G D van der Spuy; R M Warren; M Richardson; N Beyers; M A Behr; P D van Helden
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

4.  Use of spoligotyping for accurate classification of recurrent tuberculosis.

Authors:  R M Warren; E M Streicher; S Charalambous; G Churchyard; G D van der Spuy; A D Grant; P D van Helden; T C Victor
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

5.  Transposition rates of Mycobacterium tuberculosis IS6110 restriction fragment length polymorphism patterns.

Authors:  Paul H C Eilers; Dick Van Soolingen; Nguyen Thi Ngoc Lan; Rob M Warren; Martien W Borgdorff
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

6.  Molecular epidemiology of tuberculosis among immigrants in Hamburg, Germany.

Authors:  Roland Diel; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  Characterization of ancestral Mycobacterium tuberculosis by multiple genetic markers and proposal of genotyping strategy.

Authors:  Yong-Jiang Sun; Ann S G Lee; Sze Ta Ng; Sindhu Ravindran; Kristin Kremer; Richard Bellamy; Sin-Yew Wong; Dick van Soolingen; Philip Supply; Nicholas I Paton
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

8.  Sensitivities and specificities of spoligotyping and mycobacterial interspersed repetitive unit-variable-number tandem repeat typing methods for studying molecular epidemiology of tuberculosis.

Authors:  Allison N Scott; Dick Menzies; Terry-Nan Tannenbaum; Louise Thibert; Robert Kozak; Lawrence Joseph; Kevin Schwartzman; Marcel A Behr
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

9.  Spoligotyping of Mycobacterium bovis isolates found in Manitoba.

Authors:  Cyril Lutze-Wallace; Claude Turcotte; Melanie Sabourin; Gloria Berlie-Surujballi; Yvon Barbeau; Dianne Watchorn; John Bell
Journal:  Can J Vet Res       Date:  2005-04       Impact factor: 1.310

10.  Genetic diversity of Mycobacterium tuberculosis isolates from a tertiary care tuberculosis hospital in South Korea.

Authors:  Isdore Chola Shamputa; Jongseok Lee; Caroline Allix-Béguec; Eun-Jin Cho; Ji-im Lee; Vignesh Rajan; Eun Gae Lee; Jin Hong Min; Matthew W Carroll; Lisa C Goldfeder; Jin Hee Kim; Hyung Seok Kang; Soohee Hwang; Seok-Yong Eum; Seung Kyu Park; Hyeyoung Lee; Philip Supply; Sang-Nae Cho; Laura E Via; Clifton E Barry
Journal:  J Clin Microbiol       Date:  2009-12-16       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.